Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces

Nanotechnology

Volumn 25, Issue 39, 2014, Pages

  Myerson, Jacob Wheatley ^a   He, Li ^b   Allen, John Stacy ^b   Williams, Todd ^b   Lanza, Gregory ^a,b   Tollefsen, Douglas ^b   Caruthers, Shelton ^a   Wickline, Samuel ^a,b,c  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

MRI; nanomedicine; nanoparticles; thrombosis

Indexed keywords

DISEASES; KETONES; MAGNETIC RESONANCE IMAGING; MEDICAL NANOTECHNOLOGY; NANOPARTICLES;

ATHEROSCLEROTIC PLAQUE; COVALENT ATTACHMENT; PERFLUOROCARBONS; PLATELET DEPOSITION; SPECIFIC BINDING; TARGETED NANOPARTICLE; THROMBIN INHIBITORS; THROMBOSIS;

ENZYMES;

ANTICOAGULANT AGENT; NANOPARTICLE; THROMBIN;

ANIMAL; BLOOD CLOTTING; C57BL MOUSE; DRUG EFFECTS; HUMAN; MALE; METABOLISM; MOUSE; THROMBOSIS;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; THROMBIN; THROMBOSIS;

EID: 84927127641     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/25/39/395101     Document Type: Article

References (33)

1. Lee C J and Ansell J E 2011 Br. J. Clin. Pharmacology 72 581-92
2. Wann L S et al 2011 Circulation 123 1144-50
3. Li T, Zhang W W, Bai W, Zhai S and Pang Z 2010 J. Vascular Surg 52 1242-5
4. Cutlip D E et al 2007 Circulation 115 2344-51
5. Libby P 2000 Clin. Cardiology 23 3-7
6. Stone G W et al 2008 New Eng. J. Med. 358 2218-30
7. Ginsberg J S et al 2009 J. Arthroplasty 24 1-9
8. Gross P L and Weitz J I 2009 Clin. Pharmacology Therapeutics 86 139-46
9. Myerson J, He L, Lanza G, Tollefsen D and Wickline S 2011 J. Thrombosis Haemostasis 9 1292-300
10. Srivastava S, Goswami L N and Dikshit D K 2005 Medicinal Res. Rev. 25 66-92
11. Kaiser B and Hauptmann J 1992 Cardiovascular Drug Rev. 10 71-87
12. Warkentin T E, Greinacher A and Koster A 2008 Thrombosis Haemostasis 99 830-9
13. Weitz J I and Buller H R 2002 Circulation 105 1004-11
14. Myerson J W, Allen J S, Williams T A, He L, Tollefsen D M, Lanza G, Caruthers S D and Wickline S A 2012 J. Cardiovascular Magn. Reson. 14 O41
15. Kaneda M M, Caruthers S, Lanza G M and Wickline S A 2009 Ann. Biomed. Eng. 37 1922-33
16. Stone S and Hofsteenge J 1986 Biochemistry 25 4622-8
17. Weitz J I, Hudoba M, Massel D, Maraganore J and Hirsh J 1990 J. Clin. Investigation 86 385-91
18. Westrick R J, Winn M E and Eitzman D T 2007 Arteriosclerosis, Thrombosis,Vascular Biol. 27 2079-93
19. Flaim S F 1994 Artif. Cells Blood Substit. Immobil. Biotechnol. 22 1043-54
20. Flacke S et al 2001 Circulation 104 1280-5
21. Botnar R M et al 2004 Circulation 109 2023-9
22. Jaffer F A, Libby P and Weissleder R 2007 Circulation 116 1052-61
23. Jennewein C, Tran N, Paulus P, Ellinghaus P, Eble J A and Zacharowski K 2011 Mol. Med. 17 568-73
24. Laurens N, Koolwijk P and De Maat M P M 2006 J. Thrombosis Haemostasis 9 932-9
25. Palumbo J S, Talmage K E, Massari J V, La Jeunesse C M, Flick M J, Kombrinck K W, Jirouskova M and Degen J L 2004 Blood 105 178-85
26. Fernández-Ortiz A, Badimon J J, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah P K and Badimon L 1994 J. Am. Coll. Cardiology 23 1562-9
27. Smith E B 1986 Clin. Haematology 15 355-70
28. Schwartz R S, Burke A, Farb A, Kaye D, Lesser J, Henry T D and Virmani R 2009 J. Am. Coll. Cardiology 54 2167-73
29. Coughlin S 2000 Nature 407 258-64
30. Benz K and Amann K 2010 Curr. Opin. Nephrology Hypertension 19 242-7
31. Andreoli S P 2009 Pediatric Nephrology 24 253-63
32. Mickley V 2004 Nephrology Dialysis Transplantation 19 309-11
33. Vicente C P, He L, Pavao M S and Tollefsen D M 2004 Blood 104 3965-70